These data indicated that emodin inhibited the expression of NF-κB and promote pancreatic cancer cell apoptosis in vitro, thus enhancing the inhibition of cell growth and proliferation by the combined treatment. Here, NFKB1 is linked to familial pancreatic carcinoma.